PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 63 results · Obesity & Weight Management  · Clear
🔒 Subscribers only
AUTH/3333/4/20
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous complainant (self-described health professional) attended CCR (Clinical, Cosmetic, Regenerative) medical aesthetics exhibition in London (Oct 2019) and alleged Novo Nordisk promoted th…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3299/1/20
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over Saxenda materials at fertility conference lacking prominent pre
A named individual complained about Novo Nordisk’s promotion of Saxenda (liraglutide) at the British Fertility Conference (January 2020).Saxenda’s SPC (Section 4.6) stated it should not be used…
Clauses: NONE
2020 🔒 Subscribe
🔒 Subscribers only
AUTH/3245/9/19
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous, contactable individual describing themself as a GP (later noted to be assisted by an ex-employee during the appeal) complained about Novo Nordisk representatives’ promotion of Ozemp…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3198/5/19
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous, contactable complainant raised concerns about Novo Nordisk representatives’ activities linked to Saxenda (liraglutide) at obesity training meetings sponsored by Novo Nordisk and org…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3173/3/19
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous, contactable health professional complained that Novo Nordisk and its employees were linked to companies allegedly advertising, distributing and selling Saxenda (liraglutide) directly …
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3258/10/19
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code over Ozempic formulary guide omitting retinopathy risk (AUTH/3258/10
A contactable complainant (later joined by an ex-employee) complained about the promotion of Ozempic (semaglutide) by Novo Nordisk.Allegations included: company staff helping to write local formula…
Clauses: NONE
2019 🔒 Subscribe
🔒 Subscribers only
AUTH/3109/10/18
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
AstraZeneca website
A UK health professional complained about AstraZeneca UK’s HCP medicines website pages for Forxiga (dapagliflozin), Onglyza (saxagliptin) and Symbicort (budesonide/formoterol).Forxiga: complaint …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3033/4/18
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Boehringer Ingelheim Limited and Eli Lilly and Company Limited (the Alliance) complained about Novo Nordisk’s promotion of Victoza (liraglutide).Material: an exhibition panel (ref UK/VT/0318/0108…
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/3057/8/18
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
The head of prescribing and medicines management at a CCG complained about promotion of Victoza (liraglutide) by a named Novo Nordisk representative.Allegation: on 8 August 2018 the representative …
Clauses: NONE
2018 🔒 Subscribe
🔒 Subscribers only
AUTH/2793/9/15
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
AstraZeneca Forxiga EMIS Web ‘9 step guide’ ruled misleading; corrective statement and public reprim
A clinical pharmacist complained about an AstraZeneca leavepiece giving EMIS Web instructions to identify “uncontrolled and overweight” type 2 diabetes patients who “may be suitable” for Fo…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/3876/2/24
Transfers of Value Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
What happened \n \n Three university-based complainants alleged Novo Nordisk failed to properly disclose transfers of value (ToVs) to healthcare organisations (HCOs) and patient organisations (POs)…
Clauses: NONE
2015 🔒 Subscribe
🔒 Subscribers only
AUTH/2638/9/13
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi breached ABPI Code over Lyxumia cost comparison vs Bydureon in basal-insulin leavepiece (AUTH
Bristol-Myers Squibb and AstraZeneca complained about a Sanofi promotional leavepiece for Lyxumia (lixisenatide) (ref GBIE.LYX.13.04.14) focused on adding Lyxumia to basal insulin.The leavepiece in…
Clauses: NONE
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2622/7/13
HCP Hospitality & Meetings Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
An NHS clinical commissioning group employee complained about a Sanofi representative’s conduct.The representative persuaded an NHS administrative assistant to send an email (via NHS.net) to all …
Clauses: 27.1,27.2
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2600/4/13
Off-label Promotion Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
Novo Nordisk complained about Sanofi promotional materials for Lyxumia (lixisenatide): a representatives’ leavepiece (ref GBIE.LYX.13.01.14 (PRO 20055)), a one-off mailer (ref GBIE.LYX.13.02.02 (…
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2653/11/13
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Sanofi
Novo Nordisk complained about a Sanofi promotional presentation for Lyxumia (lixisenatide) used in remote (internet-based) sales calls with health professionals (ref GBIE.LYX.13.02.15).The presenta…
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2604/5/13
Off-label Promotion Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk v Sanofi
Novo Nordisk complained about a Sanofi advertisement for Lyxumia (lixisenatide) published in the Health Service Journal (March 2013) (ref GBIE.LYX.13.02.11).The ad included the claim: “Lyxumia is…
Clauses: 3.2,4.1
2013 🔒 Subscribe
🔒 Subscribers only
AUTH/2500/4/12
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Eisai breached ABPI Code over Zonegran detail aid implying weight-loss benefit (AUTH/2500/4/12)
An anonymous consultant neurologist complained that an Eisai representative’s discussion and promotional materials for Zonegran (zonisamide) implied it could be used in overweight epileptic patie…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2482/2/12
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk email invite to Diabetes UK symposium
An anonymous, contactable complainant received an email invitation (ref UK/DB/0112/0028b) to a Novo Nordisk satellite symposium at Diabetes UK 2012: “Weighing up the benefits: the practical use o…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2569/12/12
Off-label Promotion Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk detail aid for Victoza
Merck Sharp & Dohme (MSD) complained about a Novo Nordisk Victoza (liraglutide) detail aid titled “The value of Victoza” (ref UK/LR/0212/0048).The detail aid used a meta-analysis (Zinman et…
Clauses: NONE
2012 🔒 Subscribe
🔒 Subscribers only
AUTH/2382/1/11
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A general practitioner complained about Daily Mail (Mail Online) articles referring to liraglutide (Victoza), a prescription-only medicine indicated for adults with type 2 diabetes to achieve glyca…
Clauses: NONE
2011 🔒 Subscribe
🔒 Subscribers only
AUTH/2339/7/10
Data & Publications Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Anonymous Diabetes Specialist Nurse v Novo Nordisk (AUTH/2339/7/10) – Daily Telegraph articles about
An anonymous diabetes specialist nurse complained about Daily Telegraph articles about Victoza involving Novo Nordisk.The complaint was received on 29 July 2010.The PMCPA concluded the matter was o…
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2318/5/10
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Clauses: NONE
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2202/1/09
Patient Organisations Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk diabetes supplement in The Times
Eli Lilly and Company Limited complained about an article, “Gut protein drug expected to help improve control”, in a 16-page diabetes supplement (“Changing the Future of Diabetes”) distribu…
Clauses: 9.1,9.2
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2276/11/09
Patient Organisations Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Anonymous v Roche
An anonymous, non-contactable complainant alleged Roche used payments to induce prescribing of Xenical (orlistat).The allegation: a named chemist chain was paid £100,000 per year to ensure Xenical…
Clauses: NONE
2009 🔒 Subscribe
← Prev 1 2 3 Next → Page 2 of 3 — 63 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews